Lipocine Announces Continued Commercialization of TLANDO® through Verity Pharmaceuticals

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/24/2026

1. NVDA
2. JMKE
3. SPY
4. BABA
5. XPEV
6. REF
7. TSLA
8. REAX
9. USO
10. BA

Go back to Lipocine Announces Continued Commercialization of TLANDO® through Verity Pharmaceuticals
LIPOCINE (NASDAQ: LPCN) Delayed: 2.06 -0.03 (1.44%)
Previous Close $2.09    52 Week High $14.80 
Open $2.07    52 Week Low $2.51 
Day High $2.10    P/E N/A 
Day Low $2.05    EPS $-0.69 
Volume 26,726